{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:53:02Z","timestamp":1791312782209,"version":"4.3.1"},"reference-count":71,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T00:00:00Z","timestamp":1465257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The aim of this work was to evaluate the immunogenicity and neutralizing activity of sheep pox virus (SPPV; genus Capripoxvirus, family Poxviridae) structural proteins as candidate subunit vaccines to control sheep pox disease. SPPV structural proteins were identified by sequence homology with proteins of vaccinia virus (VACV) strain Copenhagen. Four SPPV proteins (SPPV-ORF 060, SPPV-ORF 095, SPPV-ORF 117, and SPPV-ORF 122), orthologs of immunodominant L1, A4, A27, and A33 VACV proteins, respectively, were produced in Escherichia coli. Western blot analysis revealed the antigenic and immunogenic properties of SPPV-060, SPPV-095, SPPV-117 and SPPV-122 proteins when injected with adjuvant into experimental rabbits. Virus-neutralizing activity against SPPV in lamb kidney cell culture was detected for polyclonal antisera raised to SPPV-060, SPPV-117, and SPPV-122 proteins. To our knowledge, this is the first report demonstrating the virus-neutralizing activities of antisera raised to SPPV-060, SPPV-117, and SPPV-122 proteins.<\/jats:p>","DOI":"10.3390\/v8060159","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T11:17:28Z","timestamp":1465298248000},"page":"159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-6246","authenticated-orcid":false,"given":"Olga","family":"Chervyakova","sequence":"first","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Zaitsev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulat","family":"Iskakov","sequence":"additional","affiliation":[{"name":"M. A. Aitkhozhin\u2019s Institute of Molecular Biology and Biochemistry, RK ME&amp;S \u2013 Science Committee, Almaty 050012, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Tailakova","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliy","family":"Strochkov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulyaisan","family":"Sultankulova","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurlan","family":"Sandybayev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan","family":"Stanbekova","sequence":"additional","affiliation":[{"name":"M. A. Aitkhozhin\u2019s Institute of Molecular Biology and Biochemistry, RK ME&amp;S \u2013 Science Committee, Almaty 050012, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniyar","family":"Beisenov","sequence":"additional","affiliation":[{"name":"M. A. Aitkhozhin\u2019s Institute of Molecular Biology and Biochemistry, RK ME&amp;S \u2013 Science Committee, Almaty 050012, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yergali","family":"Abduraimov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muratbay","family":"Mambetaliyev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abylay","family":"Sansyzbay","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, RK ME&amp;S \u2013 Science Committee, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kovalskaya","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Molecular Plant Pathology Laboratory, Beltsville, MD 20705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev.","family":"Nemchinov","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Molecular Plant Pathology Laboratory, Beltsville, MD 20705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Hammond","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Molecular Plant Pathology Laboratory, Beltsville, MD 20705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0264-410X(93)90094-E","article-title":"Control of capripoxvirus infections","volume":"11","author":"Carn","year":"1993","journal-title":"Vaccine"},{"key":"ref_2","unstructured":"World Animal Health (1996). Reports on the Animal Health Status and Disease Control Methods and Lists of Disease Outbreaks, Statistics O.I.E."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/mcpr.2000.0319","article-title":"Sheep poxvirus identification from clinical specimens by PCR, cell culture, immunofluorescence and agar gel immunoprecipitation assay","volume":"14","author":"Markoulatos","year":"2000","journal-title":"Mol. Cell. Probes"},{"key":"ref_4","unstructured":"The Center for Food Security and Public Health. Available online: http:\/\/www.cfsph.iastate.edu\/Factsheets\/pdfs\/sheep_and_goat_pox.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1865-1682.2008.01043.x","article-title":"Capripoxviruses: An emerging worldwide threat to sheep, goats and cattle","volume":"55","author":"Babiuk","year":"2008","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0950268800030016","article-title":"The characterization of African strains of capripoxvirus","volume":"102","author":"Kitching","year":"1989","journal-title":"Epidemiol. Infect."},{"key":"ref_7","first-page":"22","article-title":"Biological characterization of the sheep pox virus strain \u201cNISKhI\u201d","volume":"8","author":"Ivanyushchenkov","year":"1990","journal-title":"Veterinariya"},{"key":"ref_8","first-page":"21","article-title":"Efficacy of the dried virus vaccine based on the sheep pox virus strain \u201cNISKhI\u201d","volume":"10","author":"Kurchenko","year":"1991","journal-title":"Veterinariya"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/vr.135.14.330","article-title":"Adverse reactions in cattle to a capripox vaccine","volume":"135","author":"Yeruham","year":"1994","journal-title":"Vet. Rec."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/4298","article-title":"Out on the farm with DNA vaccines","volume":"16","author":"Beard","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"ref_11","first-page":"148","article-title":"Progress in development of viral polynucleotide (DNA) vaccines","volume":"4","author":"Ghendon","year":"1999","journal-title":"Vopr. Virusol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S1466252300000116","article-title":"A comprehensive review of goat pox and sheep pox and their diagnosis","volume":"1","author":"Rao","year":"2000","journal-title":"Anim. Health Res. Rev."},{"key":"ref_13","first-page":"26","article-title":"Comparative analysis of the protective effect of DNA-vaccines with different genes of tick-borne encephalitis virus","volume":"3","author":"Tkachyov","year":"2000","journal-title":"Immunologiya"},{"key":"ref_14","first-page":"17","article-title":"Molecular constructs of experimental combined vaccines","volume":"1","author":"Lebedev","year":"2002","journal-title":"Mol. Genet. Mikrobiol. Virusol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/JVI.77.2.1571-1577.2003","article-title":"Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections","volume":"77","author":"Berhe","year":"2003","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2009.05.031","article-title":"Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins","volume":"391","author":"Zheng","year":"2009","journal-title":"Virology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1479-5876-11-95","article-title":"L1R, A27L, A33R, and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines","volume":"11","author":"Pacchioni","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1128\/JVI.76.12.6054-6061.2002","article-title":"The genomes of sheeppox and goatpox viruses","volume":"76","author":"Tulman","year":"2002","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/JVI.74.9.4085-4092.2000","article-title":"The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses","volume":"7","author":"Betakova","year":"2000","journal-title":"J. Virol."},{"key":"ref_20","first-page":"151","article-title":"Amino acid sequence determination of vaccinia virus immunodominant protein p35 and identification of the gene","volume":"2","author":"Chertov","year":"1991","journal-title":"Biomed. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1128\/jvi.64.12.5988-5996.1990","article-title":"Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25","volume":"64","author":"Franke","year":"1990","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/jvi.62.10.3772-3778.1988","article-title":"Vaccinia virus gene D8 encodes a virion transmembrane protein","volume":"62","author":"Niles","year":"1988","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/jvi.61.11.3550-3554.1987","article-title":"Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein","volume":"61","author":"Rodriguez","year":"1987","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1128\/jvi.71.10.7404-7420.1997","article-title":"Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment","volume":"71","author":"Salmons","year":"1997","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/viro.2000.0656","article-title":"Vaccinia virus E10R protein is associated with the membranes of intracellular mature virions and has a role in morphogenesis","volume":"278","author":"Senkevich","year":"2000","journal-title":"Virology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1006\/viro.1994.1406","article-title":"N-terminal amino acid sequences of vaccinia virus structural proteins","volume":"202","author":"Takahashi","year":"1994","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1128\/JVI.74.20.9701-9711.2000","article-title":"The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis","volume":"74","author":"Yeh","year":"2000","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/jvi.66.3.1610-1621.1992","article-title":"Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress","volume":"66","author":"Duncan","year":"1992","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/viro.1993.1302","article-title":"The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence","volume":"194","author":"Engelstad","year":"1993","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/jvi.58.3.757-764.1986","article-title":"Localization and fine structure of a vaccinia virus gene encoding an envelope antigen","volume":"58","author":"Hirt","year":"1986","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/jvi.66.12.7217-7224.1992","article-title":"Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope","volume":"66","author":"Isaacs","year":"1992","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","article-title":"The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus","volume":"72","author":"Roper","year":"1998","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0042-6822(86)90309-0","article-title":"Nucleotide sequence of the vaccinia virus hemagglutinin gene","volume":"150","author":"Shida","year":"1986","journal-title":"Virology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/v4050688","article-title":"Poxvirus cell entry: How many proteins does it take?","volume":"4","author":"Moss","year":"2012","journal-title":"Viruses"},{"key":"ref_35","first-page":"707","article-title":"Detection and characterization of soluble proteins of sheep pox virus","volume":"80","author":"Malik","year":"2010","journal-title":"Indian J. Anim. Sci."},{"key":"ref_36","first-page":"41","article-title":"Soluble antigens of sheep pox and goat pox viruses as determined by immunodiffusion in agar gel","volume":"16","author":"Pandey","year":"1972","journal-title":"Acta Virol."},{"key":"ref_37","first-page":"177","article-title":"Application of electroimmunodiffusion test for detection of antigenic relationship between sheeppox and goatpox viruses","volume":"27","author":"Malik","year":"1983","journal-title":"Acta Virol."},{"key":"ref_38","first-page":"511","article-title":"Immunogenicity of soluble antigens of sheep pox virus","volume":"48","author":"Sambyal","year":"1978","journal-title":"Indian J. Anim. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jviromet.2009.08.020","article-title":"Expression of P32 protein of goatpox virus in Pichia pastoris and its potential use as a diagnostic antigen in ELISA","volume":"162","author":"Bhanot","year":"2009","journal-title":"J. Virol. Methods"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jviromet.2009.04.031","article-title":"Detection of antibodies specific for sheeppox and goatpox viruses using recombinant capripoxvirus antigens in an indirect enzyme-linked immunosorbent assay","volume":"161","author":"Bowden","year":"2009","journal-title":"J. Virol. Methods"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-0934(94)90143-0","article-title":"Use of a recombinant antigen in an indirect ELISA for detecting bovine antibody to capripoxvirus","volume":"49","author":"Carn","year":"1994","journal-title":"J. Virol. Methods"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(99)00072-1","article-title":"A capripoxvirus detection PCR and antibody ELISA based on the major antigen P32, the homolog of the vaccinia virus H3L gene","volume":"227","author":"Hein","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_44","unstructured":"Madden, T. (2013). The BLAST Sequence Analysis Tool, The NCBI Handbook [Internet], Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK153387\/."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","article-title":"Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions","volume":"83","author":"Ramirez","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0042-6822(90)90477-9","article-title":"Inducible gene expression from vaccinia virus vectors","volume":"177","author":"Rodriguez","year":"1990","journal-title":"Virology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparin sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/viro.1996.0337","article-title":"Neutralizing epitope on penetration protein of vaccinia virus","volume":"220","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-422X-6-28","article-title":"Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization","volume":"6","author":"Shinoda","year":"2009","journal-title":"Virol. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","article-title":"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","volume":"188","author":"Engelstad","year":"1992","journal-title":"Virology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","article-title":"Antibody neutralization of the extracellular enveloped form of vaccinia virus","volume":"280","author":"Law","year":"2001","journal-title":"Virology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"Fogg","year":"2007","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jvi.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1472-6750-10-83","article-title":"Recombinant expression screening of P. aeruginosa bacterial inner membrane proteins","volume":"10","author":"Madhaven","year":"2010","journal-title":"BMC Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11010-007-9603-6","article-title":"Production of active eukaryotic proteins through bacterial expression systems: A review of the existing biotechnology strategies","volume":"307","author":"Sahdev","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JVI.01854-07","article-title":"Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","volume":"82","author":"Berhanu","year":"2008","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/jvi.61.2.395-404.1987","article-title":"A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers","volume":"61","author":"Rodriguez","year":"1987","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/jvi.65.10.5631-5635.1991","article-title":"The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals","volume":"65","author":"Lai","year":"1991","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/JVI.00568-08","article-title":"Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge","volume":"82","author":"Fogg","year":"2008","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1099\/vir.0.19565-0","article-title":"Poxvirus genomes: A phylogenetic analysis","volume":"85","author":"Gubser","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"ref_69","first-page":"380","article-title":"Antigenic relationships among sheep pox, goat pox and contagious pustular dermatitis viruses","volume":"28","author":"Malik","year":"1984","journal-title":"Acta Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11262-015-1172-2","article-title":"Genetic diversity of fusion gene (ORF 117), an analogue of vaccinia virus A27L gene of carpipox virus isolates","volume":"50","author":"Dashprakash","year":"2015","journal-title":"Virus Genes"},{"key":"ref_71","unstructured":"Orlova, E.S. (2007). Improving Methods of Sheep Pox and Goat Pox Diagnosis. [Ph.D. Thesis (Biol.Sci.), Federal Centre for Animal Health (FGBI \u201cARRIAH\u201d)]."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/6\/159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:25:09Z","timestamp":1760210709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/6\/159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":71,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["v8060159"],"URL":"https:\/\/doi.org\/10.3390\/v8060159","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}